Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science

J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):161-83. doi: 10.1007/s10928-005-0062-y. Epub 2005 Nov 7.

Abstract

Few scientific contributions have made significant impact unless there was a champion who had the vision to see the potential for its use in seemingly disparate areas-and who then drove active implementation. In this paper, we present a historical summary of the development of non-linear mixed effects (NLME) modeling up to the more recent extensions of this statistical methodology. The paper places strong emphasis on the pivotal role played by Lewis B. Sheiner (1940-2004), who used this statistical methodology to elucidate solutions to real problems identified in clinical practice and in medical research and on how he drove implementation of the proposed solutions. A succinct overview of the evolution of the NLME modeling methodology is presented as well as ideas on how its expansion helped to provide guidance for a more scientific view of (model-based) drug development that reduces empiricism in favor of critical quantitative thinking and decision making.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Anticoagulants / pharmacokinetics
  • Cardiotonic Agents / pharmacokinetics
  • Digoxin / pharmacokinetics
  • Drug Industry
  • Models, Statistical*
  • Nonlinear Dynamics*
  • Pharmacokinetics*
  • Pharmacology / statistics & numerical data*
  • Pharmacology / trends*
  • Software*
  • Warfarin / pharmacokinetics

Substances

  • Anticoagulants
  • Cardiotonic Agents
  • Warfarin
  • Digoxin